<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Koutsilieris, M.</style></author><author><style face="normal" font="default" size="100%">Dimopoulos, M.A.</style></author><author><style face="normal" font="default" size="100%">Doillon, C.</style></author><author><style face="normal" font="default" size="100%">Sourla, A.</style></author><author><style face="normal" font="default" size="100%">Reyes-Moreno, C.</style></author><author><style face="normal" font="default" size="100%">Choki, I.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The molecular concept of prostate cancer</style></title><secondary-title><style face="normal" font="default" size="100%">Cancer Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diagnosis</style></keyword><keyword><style  face="normal" font="default" size="100%">hormone therapy</style></keyword><keyword><style  face="normal" font="default" size="100%">osteoblastic metastasis</style></keyword><keyword><style  face="normal" font="default" size="100%">Progression</style></keyword><keyword><style  face="normal" font="default" size="100%">Prostate cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Staging</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">1996</style></year><pub-dates><date><style  face="normal" font="default" size="100%">1996</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029929710&amp;partnerID=40&amp;md5=b616e92702e9f5a3d0eb6c89afe19fb5</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">9</style></volume><pages><style face="normal" font="default" size="100%">89 - 94</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">This is a brief presentation of the emerging molecular concept of prostate cancer as regards the diagnosis and staging of the disease, analysis of tumour response to hormone-depletion therapy, and the cellular mechanisms that underly progression of the organ-confined tumour toward systemic dissemination and inevitable lethal disease.</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><notes><style face="normal" font="default" size="100%">Cited By :24Export Date: 21 February 2017</style></notes></record></records></xml>